Drug Checking Report for Interior Health – March 2022 – BCCSU

The BCCSU publishes Provincial and regional monthly reports that summarize drug checking results. Here is the March 2022 report from samples collected by Drug Checking Sites across the Interior Health region.

Key Findings

The percentage of opioids testing positive for benzodiazepines in the region remained high (67.4%,
99 of 147 samples), but trends may be hard to infer due the large geographic region. Etizolam, the
predominant benzodiazepine in expected opioids, may be missed by drug checking technologies.
This means that the true rate may be higher than reported here.

Find the full report here.

Drug Checking Report for Interior Health – February 2022 – BCCSU

The BCCSU publishes Provincial and regional monthly reports that summarize drug checking results. Here is the February 2022 report from samples collected by Drug Checking Sites across the Interior Health region.

Key Findings

The percentage of opioids testing positive for benzodiazepines in the region fell slightly (68.5%, 61 of 89
samples) from last month, but trends may be hard to infer due to the small number of samples over a large
region. Etizolam, the predominant benzodiazepine in expected opioids, may be missed by drug checking
technologies. This means that the true rate may be higher than reported here.

2 samples of crack cocaine, 1 sample of methamphetamine, and 1 sample of flualprazolam tested positive for
fentanyl this month.

Drug checking is available in many different communities in the Interior Health region. For updated times and
locations, visit our website.

Find the full report here.

Drug Checking Report for Interior Health – December 2021 – BCCSU

The BCCSU publishes Provincial and regional monthly reports that summarize drug checking results. Here is the December 2021 report from samples collected by Drug Checking Sites across the Interior Health region.

Key Findings

The percentage of opioids testing positive for benzodiazepines in the region fell slightly (64%, 27 of 42
samples) from last month, but trends may be hard to infer due to the small number of samples over a large
region. Etizolam, the predominant benzodiazepine in expected opioids, may be missed by drug checking
technologies. This means that the true rate may be higher than reported here.

1 sample of cocaine tested positive for fentanyl and an alert was issued.

Find the full report here.

Drug checking report for Interior Health – BCCSU

Key Findings
• The percentage of opioids testing positive for benzodiazepines in the region rose sharply (68%, 42 of 62 samples) from last month, but trends may be hard to infer due to the small number of samples over a large region. Etizolam, the predominant benzodiazepine in expected opioids, may be missed by drug checking technologies. This means that the true rate may be higher than reported here.

• Heroin was detected in 17.7% of down samples in the Interior Health region in 2018 and 2019, but only 1.8% of down samples in 2021.

Read the full report.

Drug Checking Report for Interior Health – September 2021 – BCCSU

Key findings:

The percentage of opioids testing positive for benzodiazepines in the region (41%, 19 of 46 samples) increased from last month, but trends may be hard to infer due to the small number of samples over a large region. Etizolam, the predominant benzodiazepine in expected opioids, may be missed by drug checking technologies. This means that the true rate may be higher than reported here.

Fentanyl was detected in 3 stimulant samples. While these results are concerning, two of the findings can be explained by cross-contamination after purchase.

Read the full report.